CYC vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

CYC PHX
Technical
41
57
Catalyst
51
51
Sentiment
50
50
Fundamental
69
66
Momentum
39
55
Risk Gate
50
50

Key Metrics

CYC Metric PHX
$61.6MMarket Cap$79.1M
345KAvg Volume (20d)448K
N/AShort InterestN/A
$1.29052-Week High$0.200
$0.45052-Week Low$0.084
-6.7%Daily Change+0.0%
$0.490Reference Price$0.120
-49.3%ROE-5.9%
-53.3%Profit Margin-12.2%

Active Signals

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

Ask Scout AI to compare CYC and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs PKY →CYC vs REG →CYC vs RHY →CYC vs TRI →DXB vs ENL →
CYC Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).